|LETTER TO THE EDITOR
|Year : 2020 | Volume
| Issue : 3 | Page : 287-288
Successful retrieval of oocytes followed by surrogacy in hypogonadotropic hypogonadism
Kaberi Banerjee, Bhavana Singla, Priyanka Verma
Advance Fertility and Gynecology Centre, New Delhi, India
|Date of Submission||17-Mar-2020|
|Date of Decision||08-Apr-2020|
|Date of Acceptance||19-Mar-2020|
|Date of Web Publication||30-Jun-2020|
Advance Fertility and Gynecology Centre, 6, Ring Road, Lajpat Nagar 4, Moolchand Crossing, New Delhi - 110 024
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Banerjee K, Singla B, Verma P. Successful retrieval of oocytes followed by surrogacy in hypogonadotropic hypogonadism. Indian J Endocr Metab 2020;24:287-8
|How to cite this URL:|
Banerjee K, Singla B, Verma P. Successful retrieval of oocytes followed by surrogacy in hypogonadotropic hypogonadism. Indian J Endocr Metab [serial online] 2020 [cited 2021 May 8];24:287-8. Available from: https://www.ijem.in/text.asp?2020/24/3/287/288544
The new reproductive technologies such as IVF ICSI and surrogacy are becoming increasingly common, enabling infertile couples to become parents and create families. One of the rare cause of female infertility is hypogonadotropic hypogonadism (HH) which is characterized by absent or decreased function of the female ovaries. It can be defined by inappropriately low serum concentrations of LH and FSH, which is an effect of GnRH deficiency. But successful ovulation induction can be induced with gonadotropins leading to successful pregnancies in some cases.
We report a case of a 31-year-old female who came to our outpatient department with primary amenorrhea and primary infertility. We had advised the hormonal profile and the ultrasound pelvis. Serum hormonal measurements were FSH: 1.9 IU/ml, LH: 0.7 mIU/L, estradiol: <20 pg/ml, prolactin: 9.1 ng/ml, thyroid stimulating: 2.3 pg/ml. Ultrasound showed bilateral small sized ovaries with hypoplastic uterus. The husband's semen analysis was normal. She was diagnosed as a case of hypogonadotropic hypogonadism.
In view of the above diagnosis, we recommended self egg surrogacy with high dose hormones to the couple. As her FSH and LH levels were low, we stimulated her ovaries also with the highly purified menotrophin HMG 450 IU (hpHMG, Menopur; Ferring GmbH, Germany). After 7 days of stimulation, transabdominal scan showed 7 good follicles of 14 mm size in both ovaries (Patient was uncomfortable with transvaginal scan). After that daily subcutaneous injection of GnRH antagonist, 0.25 mg Cetrorelix (Cetrotide, Merck Serono S.p.A, Italy), was added. When follicles reached 18 mm, 500 mcg recombinant hCG (rhCG, Ovitrelle; Merck Serono S.p.A, Italy) was given to trigger ovulation. Transvaginal oocyte aspiration of right ovary and transabdominal oocyte aspiration of left ovary (left ovary was too high and was not approachable through vaginal route) were performed before 36 h, under ultrasound guidance, using Wallace OPU needle and Cooks gamete buffer media. We retrieved 4 oocytes from the right ovary and 3 oocytes from the left ovary and which were fertilized in the laboratory in Cooks fertilization media. Embryos were further cultured in cleavage media. 7 good embryos (grade A) were formed, out of which 3 embryos were transferred in the surrogate after preparing with long protocol method of GnRH agonist 0.5 mg inj. leuprolide acetate (Lupride; Inca Sun Pharmaceutical Industries Ltd.) and 4 embryos were frozen in one vial. After 14 days of luteal support, beta HCG was done which came positive. Ultrasound was done after 2 weeks of beta HCG that showed intrauterine singleton live pregnancy of 6 weeks. Antenatal period was uneventful. She delivered one healthy baby at 37 weeks.
The gonadotropins (FSH and LH) either urinary or recombinant can be used for ovulation induction in woman with hypogonadotropic hypogonadism for infertility. But it may require high dose or long duration of gonadotropins to stimulate the ovaries. This method yield pregnancy rates per cycle of 25-50%.,, Even low dose human chorionic gonadotrophin can be administered in the late follicular phase of the ovulation induction cycle, which may be an effective way to provide luteinizing hormone like activity in hypogonadotrophic patients., In addition to stimulating the production of intrafollicular androgens, which provide the substrate for estrogen production that enhances oocyte development, LH activity promotes development of larger follicles.
Thus, surrogacy is a viable, and only option to start families for patients with hypogonadotropic hypogonadism
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ulug U, Ben-Shlomo I, Tosun S, Erden HF, Akman MA, Bahceci M. The reproductive performance of women with hypogonadotropic hypogonadism in an in vitro
fertilization and embryo transfer program. J Assist Reprod Genet 2005;22:167-71.
Burgués S; Spanish Collaborative Group on Female Hypogonadotrophic Hypogonadism. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: Evidence from a multicentre study in Spain. Hum Reprod 2001;16:2525-32.
Kumbak B, Kahraman S. Women with hypogonadotropic hypogonadism: Cycle characteristics and results of assisted reproductive techniques. Acta Obstet Gynecol Scand 2006;85:1453-7.
Gülekl B, Doǧan E, Aydiner F, Ok E, Karagöz Akin F. Successful pregnancy in a woman with hypogonadotrophic hypogonadism using low dose hCG after priming with recombinant FSH in an IVF cycle. J Turk Ger Gynecol Assoc 2007;8:428-30.
Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT. Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertil Steril 1999;72:1118-20.